Stockholders’ Equity (Deficit) - Schedule of Nonvested Restricted Stock Shares Activity (Details) - $ / shares		9 Months Ended
	Sep. 21, 2023	Sep. 30, 2023
Weighted-Average Grant-Date Fair Value per Share
Non-voting common stock withheld for tax obligation and net settlement (in shares)	20,810,882
Restricted Stock
Number of Shares
Unvested and outstanding, beginning of period (in shares)		828,000
Granted (in shares)		0
Vested (in shares)		(453,000)
Options forfeited (in shares)		0
Unvested and outstanding, ending of period (in shares)		375,000
Weighted-Average Grant-Date Fair Value per Share
Unvested and outstanding, beginning of period, weighted average exercise price (in dollars per share)		$ 97.99
Granted, weighted average exercise price (in dollars per share)		0
Vested, weighted average exercise price (in dollars per share)		106.44
Forfeited, weighted average exercise price (in dollars per share)		0
Unvested and outstanding, ending of period, weighted average exercise price (in dollars per share)		$ 87.80
Non-voting common stock withheld for tax obligation and net settlement (in shares)		162,886